Profile and variability of intraocular pressure after the EX-PRESS device implant
Abstract Objective: The EX-PRESS device is a surgical alternative for the treatment of POAG. To describe the IOP behavior before and after the implantation of the EX-PRESS, the pharmacological treatment used in the pre and postoperative period and the complications in the first year of the postoper...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Oftalmologia
2019-12-01
|
Series: | Revista Brasileira de Oftalmologia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802019000600364&tlng=en |
_version_ | 1798022073784729600 |
---|---|
author | Rodrigo Egidio da Silva Juliana de Lima Jácomo Lara Ribeiro Vilela Antônio Wilson Soares de Oliveira Francisco Wellington Rodrigues |
author_facet | Rodrigo Egidio da Silva Juliana de Lima Jácomo Lara Ribeiro Vilela Antônio Wilson Soares de Oliveira Francisco Wellington Rodrigues |
author_sort | Rodrigo Egidio da Silva |
collection | DOAJ |
description | Abstract Objective: The EX-PRESS device is a surgical alternative for the treatment of POAG. To describe the IOP behavior before and after the implantation of the EX-PRESS, the pharmacological treatment used in the pre and postoperative period and the complications in the first year of the postoperative period. Methods: A quantitative descriptive study with review of electronic medical records of a private ophthalmological reference hospital in Goiânia (GO) from 2013 to 2018. Sample composed of 8 eyes with POAG subjected to the EX-PRESS implant. We observed the variables: gender, age, operated eye, antiglaucomatous medications used, pre and postoperative intraocular pressure, and possible complications. Results: In the preoperative period, all eyes used antiglaucomatous drops, 75% used 3 or more different classes simultaneously. After 12 months of EX-PRESS, only 12.5% used three or more eye drops and 37.5% did not use any eye drops. On average, IOP varied from 18.63mmHg (SD 9.38) in the preoperative period to 14.50mmHg (SD 4.14) at 12 months postoperatively. Complications were: ocular hypotension, ocular hypertension; thinning of the conjunctival blister, cystic blister obstruction of the EX-PRESS. We resolved all coplications. Conclusion: The efficacy of EX-PRESS in IOP reduction was verified in the study. Concomitantly, there was a considerable decrease in anti-glaucomatous medications, and few associated complications. |
first_indexed | 2024-04-11T17:23:53Z |
format | Article |
id | doaj.art-cf9513ee60a14b23ac63adbbb3b1505f |
institution | Directory Open Access Journal |
issn | 1982-8551 |
language | English |
last_indexed | 2024-04-11T17:23:53Z |
publishDate | 2019-12-01 |
publisher | Sociedade Brasileira de Oftalmologia |
record_format | Article |
series | Revista Brasileira de Oftalmologia |
spelling | doaj.art-cf9513ee60a14b23ac63adbbb3b1505f2022-12-22T04:12:25ZengSociedade Brasileira de OftalmologiaRevista Brasileira de Oftalmologia1982-85512019-12-0178636436910.5935/0034-7280.20190162Profile and variability of intraocular pressure after the EX-PRESS device implantRodrigo Egidio da Silvahttps://orcid.org/0000-0002-8072-4767Juliana de Lima Jácomohttps://orcid.org/0000-0003-1971-3695Lara Ribeiro VilelaAntônio Wilson Soares de Oliveirahttps://orcid.org/0000-0001-6728-5934Francisco Wellington Rodrigueshttps://orcid.org/0000-0002-7995-0273Abstract Objective: The EX-PRESS device is a surgical alternative for the treatment of POAG. To describe the IOP behavior before and after the implantation of the EX-PRESS, the pharmacological treatment used in the pre and postoperative period and the complications in the first year of the postoperative period. Methods: A quantitative descriptive study with review of electronic medical records of a private ophthalmological reference hospital in Goiânia (GO) from 2013 to 2018. Sample composed of 8 eyes with POAG subjected to the EX-PRESS implant. We observed the variables: gender, age, operated eye, antiglaucomatous medications used, pre and postoperative intraocular pressure, and possible complications. Results: In the preoperative period, all eyes used antiglaucomatous drops, 75% used 3 or more different classes simultaneously. After 12 months of EX-PRESS, only 12.5% used three or more eye drops and 37.5% did not use any eye drops. On average, IOP varied from 18.63mmHg (SD 9.38) in the preoperative period to 14.50mmHg (SD 4.14) at 12 months postoperatively. Complications were: ocular hypotension, ocular hypertension; thinning of the conjunctival blister, cystic blister obstruction of the EX-PRESS. We resolved all coplications. Conclusion: The efficacy of EX-PRESS in IOP reduction was verified in the study. Concomitantly, there was a considerable decrease in anti-glaucomatous medications, and few associated complications.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802019000600364&tlng=enGlaucoma drainage implantsGlaucomaIntraocular pressureDrug therapyPostoperative complicationsProsthesis implantation/methods |
spellingShingle | Rodrigo Egidio da Silva Juliana de Lima Jácomo Lara Ribeiro Vilela Antônio Wilson Soares de Oliveira Francisco Wellington Rodrigues Profile and variability of intraocular pressure after the EX-PRESS device implant Revista Brasileira de Oftalmologia Glaucoma drainage implants Glaucoma Intraocular pressure Drug therapy Postoperative complications Prosthesis implantation/methods |
title | Profile and variability of intraocular pressure after the EX-PRESS device implant |
title_full | Profile and variability of intraocular pressure after the EX-PRESS device implant |
title_fullStr | Profile and variability of intraocular pressure after the EX-PRESS device implant |
title_full_unstemmed | Profile and variability of intraocular pressure after the EX-PRESS device implant |
title_short | Profile and variability of intraocular pressure after the EX-PRESS device implant |
title_sort | profile and variability of intraocular pressure after the ex press device implant |
topic | Glaucoma drainage implants Glaucoma Intraocular pressure Drug therapy Postoperative complications Prosthesis implantation/methods |
url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802019000600364&tlng=en |
work_keys_str_mv | AT rodrigoegidiodasilva profileandvariabilityofintraocularpressureaftertheexpressdeviceimplant AT julianadelimajacomo profileandvariabilityofintraocularpressureaftertheexpressdeviceimplant AT lararibeirovilela profileandvariabilityofintraocularpressureaftertheexpressdeviceimplant AT antoniowilsonsoaresdeoliveira profileandvariabilityofintraocularpressureaftertheexpressdeviceimplant AT franciscowellingtonrodrigues profileandvariabilityofintraocularpressureaftertheexpressdeviceimplant |